Artrya

About:

Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.

Website: https://www.artrya.com/

Twitter/X: Artrya1

Top Investors: Thorney Investment, Regal Funds Management, Washington H. Soul Pattinson, Watermark Funds Management

Description:

Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease. Left undiagnosed, patients remain at risk, incorrect treatment regimes are administered and cost burdens on health systems escalate. With ageing populations and the demand for medical services rising globally, significant delays in reporting can leave patients in critical situations.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Perth, Western Australia, Australia

Founded Date:

2019-01-01

Contact Email:

contact(AT)artrya.com

Founders:

John Barrington, John Konstantopoulos

Number of Employees:

11-50

Last Funding Date:

2021-05-25

IPO Status:

Public

© 2024 MyAiNote.com